Talin Haritunians
Appearances
- DateMay 9, 2023INTRODUCTION: We aimed to investigate the relationship between consumption of ultra-processed foods (UPFs) and: 1) active symptomatic disease and 2) intestinal inflammation in a cohort of adults living with inflammatory bowel disease (IBD)…
Presenter
Speakers
Cedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 9, 2023INTRODUCTION: We aimed to investigate the relationship between consumption of ultra-processed foods (UPFs) and: 1) active symptomatic disease and 2) intestinal inflammation in a cohort of adults living with inflammatory bowel disease (IBD)…
Presenter
Speakers
Cedars-Sinai Medical CenterEmory UniversityUniversity of Miami Miller School of MedicineCedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 9, 2023BACKGROUND: Cancer is a major cause of morbidity and mortality in persons with inflammatory bowel disease (IBD). We evaluated temporal trends and relative risks of intestinal and extra-intestinal cancers among persons with IBD and matched controls…
Presenter
Speakers
Cedars-Sinai Medical CenterCedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 19, 2024BACKGROUND: Although incidence of Inflammatory Bowel Disease (IBD) is rising in underrepresented populations, including Hispanics, genetic studies of IBD have primarily focused on Northern European ancestral populations…
Presenter
Speakers
Cedars-Sinai Medical CenterCedars-Sinai Medical CenterUniversity of Miami Miller School of MedicineIcahn School of Medicine at Mount SinaiCedars-Sinai Medical Center - DateMay 19, 2024Genetic and environmental influences contribute to Crohn’s disease (CD) development. However, the relationship between these two factors is unclear, limiting insights into CD pathophysiology, as well as interventions to prevent disease…
Presenter
Rutgers Robert Wood Johnson Medical SchoolSpeakers
Cedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 18, 2024Background: _LRRK2_ variants (G2019S/N2081D) that increase Parkinson’s disease (PD) and Crohn’s Disease (CD) susceptibility are associated with LRRK2 kinase hyperactivity and suppress autophagy, suggesting that LRRK2 kinase inhibition, a strategy being explored for PD treatment, may also benefit CD…
Speakers
Cedars-Sinai Medical CenterPresenter